QUALITY CONTROL MEASUREMENT AND IN VITRO BIOEQUIVALENCE OF VALSARTAN AND ATENOLOL TABLETS MARKETED IN UKRAINE
DOI:
https://doi.org/10.11603/ijmmr.2413-6077.2020.2.12013Keywords:
hypertension, valsartan, atenolol, high-performance liquid chromatography, in vitro bioequivalence, dissolutionAbstract
Background. The urgent issue of hypertension is determined by its high population incidence, significant burden of the disease, risk of disability and impact on life expectancy. Rational combinations of drugs of different pharmacological groups in case of ineffectiveness of monotherapy to achieve the clinical effect of pharmacotherapy are clearly recommended in the world and national recommendations for diagnosis and treatment of hypertension. Therefore, innovative pharmaceutical development of a combination of antihypertensive drugs and creation of domestic drugs with antihypertensive action is an urgent task of contemporary pharmacy.
Objective. The aim of this study was to perform the quality control measurements and evaluation of dissolution tests for different brands of valsartan and atenolol tablets available in Ukraine.
Methods. The concentrations of valsartan and atenolol in samples (drug content and dissolution study) were determined by the proposed HPLC method.
Results. The results of the tests conducted for evaluation of the tablets were found to be in acceptable limits for all the selected brands. The correlation coefficient (R2) was 0.9991 and the regression equation was y=61.39x+0.3117. It has been established that the equivalence of dissolution profiles for all recommended dissolution media is observed (рН 1.2, 4.5, and 6.8) for the studied drugs. In all three dissolution media, the release rates of valsartan and atenolol of all dosage forms are more than 85% in 15 min. The dissolution profile of all the selected brands was within the standard limits and was acceptable.
Conclusions. Analytical method development is an integral part of the quality control measurements and evaluation of dissolution tests. Our previously developed HPLC method is essential for quality control of a large number of samples in short time intervals. Therefore, the method developed by our group is suitable for a routine quality control analysis of any pharmaceutical preparation containing two tested drugs with the suggested chromatographic method advantages for checking quality during dissolution studies of their dosage forms.
References
Gupta KR, Wadodkar AR, Wadodkar SG. UV Spectrophotometric methods for estimation of Valsartan in bulk and tablet dosage form. International Journal of ChemTech Research. 2010;2:985-89.
Rao GS, Rao GV, Vardhan S, Ramachandran D. Development and validation of new UV-spectrophotometric assay method for valsartan in pure and in formulations. Journal of Chemical and Pharmaceutical Research. 2013;5:229-32.
Ramachandran S, Mandal BK, Navalgund SG. Simultaneous spectrophotometric determination of valsartan and ezetimibe in pharmaceuticals. Tropical Journal of Pharmaceutical Research 2011;10:809-15.
DOI: https://doi.org/10.4314/tjpr.v10i6.15
Nikam MB, Dhamane H, Aligave A, Kondawar MS. Simultaneous estimation of valsartan, amlodipine besylate and hydrochlorothiazide by first order derivative UV spectrophotometric method. Int J Pharm Technol. 2010;2:642-50.
Selvan PS, Gowda KV, Mandal U, Solomon WDS, Pal TK. Simultaneous determination of fixed dose combination of nebivolol and valsartan in human plasma by liquid chromatographic-tandem mass spectrometry and its application to pharmacokinetic study. Journal of Chromatography B. 2007;858:143-50.
DOI: https://doi.org/10.1016/j.jchromb.2007. 08.016
Sabi-mouka EMB, Agbokponto JE, Zhang R, Li Q, Ding L. Simultaneous determination of a fixeddose combination of lercanidipine and valsartan in human plasma by LC–MS-MS: Application to a pharmacokinetic study. Journal of chromatographic science. 2016;54:1553-59.
DOI: https://doi.org/10.1093/chromsci/bmw102
Koseki N, Kawashita H, Hara H, Niina M, Tanaka M, Kawai R, Nagae Y, Masuda N. Development and validation of a method for quantitative determination of valsartan in human plasma by liquid chromatography-tandem mass spectrometry. Journal of pharmaceutical and biomedical analysis. 2007;43:1769-74.
DOI: https://doi.org/10.1016/j.jpba.2006.12.030
Tian DF, Tian XL, Tian T, Wang ZY, Mo FK. Simultaneous determination of valsartan and hydrochlorothiazide in tablets by RP-HPLC. Indian journal of pharmaceutical sciences. 2008;70:372.
DOI: https://doi.org/10.4103/0250-474X.43006
Chitlange SS, Bagri K, Sakarkar DM. Stability Indicating RP-HPLC Method for Simultaneous Estimation of Valsartan and Amlodipine in Capsule Formulation. Asian Journal of Research in Chemistry. 2008;1:15-18.
Galande VR, Baheti KG, Indraksha S, Dehghan MH. Estimation of amlodipine besylate, valsartan and hydrochlorothiazide in bulk mixture and tablet by UV spectrophotometry. Indian journal of pharmaceutical sciences. 2011;74:18.
DOI: https://doi.org/10.4103/0250-474X.102538
Liu F, Zhang J, Xu Y, Gao S, Guo Q. Simultaneous determination of hydrochlorothiazide and valsartan in human plasma by liquid chromatography/tandem mass spectrometry. Analytical Letters. 2008;41:1348-65.
DOI: https://doi.org/10.1080/00032710802119186
Thanusha G, Jose C, Babu G, Basavaraj KPC, Panditi VR, Sharadha C. Validated RP-HPLC method for the quantitative estimation of valsartan in bulk and pharmaceutical dosage forms. International Journal of ChemTech Research. 2010;2:1194-98.
Kumar PVS, Sahu M, Prasad KD, Shekhar MC. Development and validation of analytical method for the estimation of valsartan in pure and tablet dosage form by RP-HPLC method. Int. J. Res. Pharm. Chem. 2011;1:945-49.
Vinzuda DU, Sailor GU, Sheth NR. RP-HPLC method for determination of valsartan in tablet dosage form. International Journal of ChemTech Research. 2010;2:1461-67.
Kendre MD, Banerjee SK. Precise and accurate RP-HPLC method development for quantification of valsartan in tablet dosage form. International Journal of Pharmaceutical Sciences and Drug Research. 2012;4:137-39.
Gonzalez L, Lopez JA, Alonso RM, Jimenez RM. Fast screening method for the determination of angiotensin II receptor antagonists in human plasma by high-performance liquid chromatography with fluorimetric detection. Journal of Chromatography A. 2002;949:49-60.
DOI: https://doi.org/10.1016/S0021-9673(01)01496-0
Lalitha G, Salomi P, Ravindra RK. Development of an analytical method and its validation for the analysis of atenolol in tablet dosage form by UV-Spectrophotometry. International Journal of Pharmacy and Pharmaceutical Sciences. 2013;5: 197–99.
Attia KA-SM, Nassar MW, Abolmagd E. Simultaneous spectrophotometric determination of amlodipine and atenolol in pharmaceutical preparations using chemometric techniques. ACAIJ. 2016;16:205-10.
Lalitha KV, Kiranjyothi R, Padma B. UV Spectrophotometric method development and validation for the determination of Atenolol and Losartan Potassium by Q-analysis. International Bulletin of Drug Research. 2013;3:54-62.
Agarwal R, Gfadnis A. Kinetic spectrophotometric determination of atenolol in perchloric acid medium. International Journal of Pharmacy and Pharmaceutical Sciences. 2012;4:350-52.
Basavaiah K, Chandrashekar U, NagegowdaP. Titrimetric, spectrophotometric and kinetic methods for the assay of atenolol using bromate-bromide and methyl orange. Journal of the Serbian Chemical Society. 2006;71:553-63.
DOI: https://doi.org/10.2298/JSC0605553B
Pai NR, Patil SS. Development and validation of liquid chromatographic method for atenolol and its related substance. Der Pharm. Sin. 2013;4:76-84.
Naikini P, Akula A, Ajitha A, Rao VUM. RP-HPLC method development and validation for the simultaneous estimation of amlodipine and atenolol in bulk and tablet dosage forms. International Journal of Pharmacy and Pharmaceutical Sciences. 2014;6:390-94.
Chaudhari V, Hussian S, Ubale M. A newer validated and stability indicating HPLC method for the estimation of Atenolol and Hydrochlorothiazide in bulk drug and dosage form. International Journal of Chemical Studies. 2013;1:93-101.
Belal F, Sharaf M, Aly F, Hefnawy M, Awady M. Stability-indicating HPLC Method for the Determination of Atenolol in Pharmaceutical Preparations. J Chromat Separation Techniq. 2013;4:1-7.
Yilmaz B, Arslan S, Determination of atenolol in human urine by gas chromatography-mass spectrometry method. Journal of chromatographic science. 2011;49:365-69.
DOI: https://doi.org/10.1093/chromsci/49.5.365
Tengli AR, Gurupadayya BM. Method development and validation of tablet dosage form containing losartan, atenolol and hydrochlorthiazide using internal standard by RP-HPLC. J Chromat Separation Techniq. 2013;4:1-5.
Gradman AH, Basile JN, Carter BL, Bakris GL. American Society of Hypertension Writing, G., Combination therapy in hypertension. Journal of the American Society of Hypertension. 2010;4:90-98.
DOI: https://doi.org/10.1016/j.jash.2010.03.001
Hanson R, Gray V. Handbook on Dissolution Testing. 3rd ed. Publisher: Dissolution Technologiesgies, USA, 2004. 199 р.
Guidance for industry: Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a Biopharmaceutics Classification System / U.S. Department of Health and Human Services, Food and Drug Administration (HHS-FDA). Center for Drug Evaluation and Research (CDER). 2017. URL: https://www.fda.gov/media/70963/download
DOI: http://academy.gmp-compliance.org/guidemgr/files/UCM070246.PDF.
Popy FA, Dewan I, Parvin MN, Islam SMA. Evaluation of in vitro equivalence for tablets containing the poorly water-soluble compound atorvastatin. Dissol Technol. 2012;19(4):30-33.
DOI: https://doi.org/10.14227/DT190412P30
Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13:123–33.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 International Journal of Medicine and Medical Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who sent their manuscript to International Journal of Medicine and Medical Research agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License CC-BY-NC that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
